Celldex Therapeutics Statistics
Total Valuation
CLDX has a market cap or net worth of $1.79 billion. The enterprise value is $998.58 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CLDX has 66.34 million shares outstanding. The number of shares has increased by 28.81% in one year.
Current Share Class | 66.34M |
Shares Outstanding | 66.34M |
Shares Change (YoY) | +28.81% |
Shares Change (QoQ) | +0.42% |
Owned by Insiders (%) | 0.29% |
Owned by Institutions (%) | 104.76% |
Float | 62.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 160.95 |
Forward PS | 1,993.67 |
PB Ratio | 2.23 |
P/TBV Ratio | 2.31 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 100.10 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.27, with a Debt / Equity ratio of 0.00.
Current Ratio | 24.27 |
Quick Ratio | 23.58 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.84% and return on invested capital (ROIC) is -20.96%.
Return on Equity (ROE) | -29.84% |
Return on Assets (ROA) | -19.73% |
Return on Capital (ROIC) | -20.96% |
Revenue Per Employee | $62,350 |
Profits Per Employee | -$962,981 |
Employee Count | 160 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.25% in the last 52 weeks. The beta is 1.59, so CLDX's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | -9.25% |
50-Day Moving Average | 30.87 |
200-Day Moving Average | 36.93 |
Relative Strength Index (RSI) | 46.05 |
Average Volume (20 Days) | 1,120,734 |
Short Selling Information
The latest short interest is 8.24 million, so 12.42% of the outstanding shares have been sold short.
Short Interest | 8.24M |
Short Previous Month | 8.40M |
Short % of Shares Out | 12.42% |
Short % of Float | 13.14% |
Short Ratio (days to cover) | 9.03 |
Income Statement
In the last 12 months, CLDX had revenue of $9.98 million and -$154.08 million in losses. Loss per share was -$2.53.
Revenue | 9.98M |
Gross Profit | -137.06M |
Operating Income | -174.18M |
Pretax Income | -150.22M |
Net Income | -154.08M |
EBITDA | -171.06M |
EBIT | -174.18M |
Loss Per Share | -$2.53 |
Full Income Statement Balance Sheet
The company has $756.00 million in cash and $3.09 million in debt, giving a net cash position of $752.91 million or $11.35 per share.
Cash & Cash Equivalents | 756.00M |
Total Debt | 3.09M |
Net Cash | 752.91M |
Net Cash Per Share | $11.35 |
Equity (Book Value) | 785.91M |
Book Value Per Share | 11.85 |
Working Capital | 746.75M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$157.84 million and capital expenditures -$1.83 million, giving a free cash flow of -$159.66 million.
Operating Cash Flow | -157.84M |
Capital Expenditures | -1.83M |
Free Cash Flow | -159.66M |
FCF Per Share | -$2.41 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -1,745.97% |
Pretax Margin | -1,544.48% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,480.75% |
Dividends & Yields
CLDX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -28.81% |
Shareholder Yield | -28.81% |
Earnings Yield | -8.80% |
FCF Yield | -9.12% |
Dividend Details Analyst Forecast
The average price target for CLDX is $64.83, which is 140.47% higher than the current price. The consensus rating is "Buy".
Price Target | $64.83 |
Price Target Difference | 140.47% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 126.86% |
EPS Growth Forecast (5Y) | -8.56% |
Stock Forecasts Stock Splits
The last stock split was on February 11, 2019. It was a reverse split with a ratio of 0.0666666:1.
Last Split Date | Feb 11, 2019 |
Split Type | Reverse |
Split Ratio | 0.0666666:1 |
Scores
CLDX has an Altman Z-Score of 33.69 and a Piotroski F-Score of 3.
Altman Z-Score | 33.69 |
Piotroski F-Score | 3 |